Science | Nature | Cell | View More
Natural Products
Catalog No. Information
CFN96346 Ligucyperonol

Ligucyperonol exhibits significant activities on protecting muscle cells from mild to moderate oxidative stress.
CFN96306 Dehydroborapetoside B

Reference standards.
CFN96298 Borapetoside B

Standard reference
CFN96291 5-Hydroxy-1,7-bis(4-hydroxyphenyl)heptan-3-yl acetate

Reference standards.
CFN96275 1-(3,4-Dihydroxyphenyl)-7-(4-hydroxyphenyl)heptane-3,5-diyl diacetate

Reference standards.
CFN96274 Borapetoside E

Borapetoside E has anti-hyperglycemic activity, it can significantly reduce serum glucose levels at dose-dependent manners in alloxan-induced hyperglycemic mice and db/db type 2 diabetic mice.
CFN96266 Eudesmin

Eudesmin shows antiinflammatory, neuritogenic, anticonvulsant and sedative effects, the mechanism of eudesmin may be related to up-regulation of GABAA and GAD65 expressions, and anti-apoptosis of neuron the in brain.50 microM (+)-eudesmin can induce neurite outgrowth and enhance nerve growth factor (NGF)-mediated neurite outgrowth from PC12 cells by stimulating up-stream MAPK, PKC and PKA pathways.
CFN95009 6-Hydroxywogonin

CFN94832 Raddeanoside R8

Raddeanoside R8 is a natural product from Anemone raddeana Regel.
CFN95008 Isonemerosin

Reference standards.
CFN95007 8,8''-Bibaicalein

8,8''-Bibaicalein is a natural product from Scutellaria baicalensis.
CFN94466 Quercetin-3-O-glucose-6''-acetate

Quercetin-3-O-glucose-6''-acetate is a NADPH oxidase inhibitor, it has antioxidant capacity.
CFN90868 Picroside IV

Kutkoside is a mixture of iridoid glycosides namely, picroside II, Picroside IV and 6-ferulloylcatalpol, it may have antinociceptive and anti-inflammatory effects.
CFN90864 meso-Hannokinol

meso-Hannokinol and (+)-hannokinol can significantly inhibit lipopolysaccharide-induced nitric oxide production in BV2 microglial cells at concentrations ranging from 1 uM to 100 uM.
CFN90861 Continentalic acid

Continentalic acid and kaurenoic acid are quality control markers in Aralia continentalis. Continentalic acid has anti-inflammatory, anti-cancer, and anti-bacterial activities, it shows moderate cytotoxicity against A-549 (lung), THP-1 (leukemia) and MCF-7 (breast) cell lines; it has minimum inhibitory concentrations (MICs) of approximately 8-16 microg/mL against S. aureus, including the MSSA and MRSA standard strains.
CFN96255 Lupeolic acid

Lupeolic acid has anti-inflammatory activity.
CFN96248 Hannokinol

(+)-Hannokinol and MESO-hannokinol can significantly inhibit lipopolysaccharide-induced nitric oxide production in BV2 microglial cells at concentrations ranging from 1 microM to 100 microM.
CFN96238 Juglanin

Juglanin has anti-tumor, antioxidant,and hepatoprotective activities. Juglanin shows protective effects on fructose-induced hepatitis by inhibiting inflammation and apoptosis through TLR4 and JAK2/STAT3 signaling pathways in fructose-fed rats. Juglanin can lead to G2/M phase arrest, induce apoptosis as well as autophagy through the ROS/JNK signaling pathway in human breast cancer cells
CFN90858 4,5-Di-O-caffeoylquinic acid methyl ester

4,5-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV.
CFN90857 3,5-Di-O-caffeoylquinic acid methyl ester

3,5-Di-O-caffeoylquinic acid methyl ester exhibits potent inhibitory activities against the formation of advanced glycation end products (AGEs); it exhibits cytotoxicity actions against human cervix carcinoma HeLa cells. 3,5-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV.
CFN90856 3,4-Di-O-caffeoylquinic acid methyl ester

3,4-Di-O-caffeoylquinic acid methyl ester shows high efficiency and low toxicity with antivirus activity against RSV; it exhibits cytotoxicity actions against human cervix carcinoma HeLa cells.
CFN96224 Kaempferol 7-O-rhamnoside

Kaempferol 7-O-rhamnoside is a natural product from Maytenus hookeri.
CFN96221 3,7-Di-O-methylquercetin

3,7-Di-O-methylquercetin shows α-glucosidase inhibition.
CFN90855 Quercetagetin-7-O-glucoside

Quercetagetin-7-O-glucoside, a potent inhibitor of beta-glucuronidase and lysozyme release, shows anti-inflammatory activity, can significantly inhibit arachidonic acid release from membranes.
CFN90839 Isomucronulatol

Isoliquiritigenin and liquiritigenin exhibit significant inhibitory effects on LPS-induced IL-6 and IL-12 p40 production, with IC 50 values ranging from 2.7 to 6.102uM, isoliquiritigenin also shows a moderate inhibitory effect on LPS-stimulated production of TNF-α with an IC 50 value of 20.102 uM, they have potential anti-inflammatory effects. Isomucronulatol exhibits noticeable ABTS+ scavenging activity, it exhibits moderate inhibition against butyrylcholinesterase.
CFN90838 Methylnissolin

Methylnissolin is a natural product from A. membranaceus.
CFN92889 5-O-Feruloylquinic acid

5-O-feruloylquinic acid is a potent Sirt1 agonist, it is a potential lead compound that can be further tested in drug development process for diseases associated with aging.
CFN95006 cis-Mulberroside A

cis-Mulberroside A shows high analgesic and anti-inflammatory activities, it can protect mice against ethanol-induced hepatic damage.
CFN90831 Galloylpaeoniflorin

Galloylpaeoniflorin exhibits anticomplement effects, it reveals a more pronounced radical scavenging effect than a-tocopherol. Galloylpaeoniflorin can take part in improving blood circulation by inhibiting ether platelet aggregation and/or blood coagulation. Galloylpaeoniflorin exhibits good activity on acute lung injury.
CFN90830 3,3'-Di-O-methylellagic acid 4'-glucoside

Reference standards.
CFN90829 20(21)-Dehydrolucidenic acid A

20(21)-dehydrolucidenic acid A is a natural product from Ganoderma lucidum.
CFN90827 Rubrofusarin-6-O-beta-D-gentiobioside

Rubrofusarin-6-O-beta-D-gentiobioside can significantly decrease the expression of TGF-beta1 and fibronectin and NF-kappaB DNA binding activity, suggests that it has potential as a preventive agent for advanced glycation end products-related diabetic complications.
CFN90826 Cassiaside

Cassiaside has significant hepato-protective effects against galactosamine damage, which is higher than that of silybin from Silybum marianum. Cassiaside demonstrates significant antimutagenic, and 1,1-diphenyl-2-picrylhydrazyl(DPPH) radical scavenging effects. Cassiaside and emodi show mixed-type inhibition against β-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1).
CFN95005 Apterin

Apterin has anti-inflammatory activity in vitro, it shows significantly inhibitory activity on nitric oxide production in RAW264.7 cells.
CFN95004 Decuroside I

Decuroside I shows weak inhibiting activity against the primary and secondary wave aggregation of human platelet.
CFN95003 Pd-C-II

Pd-C-II has anti-inflammation activity, it can inhibit TNF-α production and iNOS protein expression and inhibit COX-2 protein expression in LPS-stimulated RAW 264.7 cells. Pd-C-II inhibits anaphylactic mediator release from purified mast cells induced by concanavalin A with phosphatidylserine, the IC50 value of 79 microM.
CFN95002 Decursitin D

Decursitin D is a natural product from the roots of Peucedanum decursivum.
CFN95001 Oroselol

Oroselol, jatamansinol, nardostachysin, jatamansinone and nardosinone are Nardostachys jatamansi rhizome extract marker compounds.
CFN90819 Mauritianin

Mauritianin and (+)-syringaresinol as new topoisomerase I inhibitors. Mauritianin has statistically significant cytoprotective activity similar to that of silymarin, tested at 60 ug/mL.
CFN90818 Semilicoisoflavone B

Semilicoisoflavone B can inhibit sorbitol formation of rat lens incubated with a high concentration of glucose, indicates that it may be effective for preventing osmotic stress in hyperglycemia.
CFN90817 Glycyrrhisoflavone

Glycyrrhisoflavone is a tyrosinase inhibitor, it also shows inhibitory effects on monoamine oxidase. Glycybenzofuran shows significant protein tyrosine phosphatase-1B (PTP1B) inhibitory activity in vitro with the IC50 value of 25.5 microM. Glycyrrhisoflavone has anti-inflammatory effects, it has significant inhibitory effects against NO production on LPS-induced RAW 264.7 cell model.
CFN90816 Licoisoflavone A

Licoisoflavone A is a potential MRP inhibitor, it shows inhibitory effects on copper-induced protein oxidative modification of mice brain homogenate in vitro.
CFN90815 Effusol

Effusol can induce caspase-3-mediated cytotoxicity in HT22 cells.
CFN90814 Dehydroeffusol

Dehydroeffusol possesses anti-cancer, anxiolytic and sedative properties, it may antagonize the spasmogenic activity of various agents, and therefore, could be a promising agent in the treatment of spasms. Dehydroeffusol displays enhanced antimicrobial activities in light, its antimicrobial activities (minimum inhibitory concentrations) against methicillin-resistant and -sensitive Staphylococcus aureus and Candida albicans are increased 16 fold by irradiation with ultraviolet A (UVA).
CFN90813 Juncusol

Juncusol shows anxiolytic and sedative activities, it shows anxiolytic activity at dosages of 10 mg/kg; it can induce caspase-3-mediated cytotoxicity in HT22 cells. Juncusol has anti-microbial activity, it shows significant activity against MRSA strains.
CFN90810 9'''-Methyl salvianolate B

Reference standards.
CFN90804 3-O-Acetyl-16 alpha-hydroxytrametenolic acid

3-O-Acetyl-16 alpha -hydroxytrametenolic acid has inhibitory activities against AAPH-induced hemolysis of red blood cells, it shows a strong inhibitory activity against 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice. 3-O-Acetyl-16 alpha-hydroxytrametenolic acid markedly inhibited the promoting effect of 12-O-tetradecanoylphorbol-13-acetate (1 microgram/mouse) on skin tumor formation following initiation with 7,12-dimethylbenz[a]anthracene (50 micrograms/mouse).
CFN93114 Parishin C

Parishin C has antipsychotic effects, requires activation of 5-HT(1A) receptors, it can prevent vascular dementia.
CFN93113 Parishin B

Parishin B has good neuroprotective effects against brain disorders, it can prevent vascular dementia.
CFN93112 Parishin A

Parishin A has good neuroprotective effects against brain disorders.